4 free views remaining today
MELAS syndrome
ICD-10 Codes
Related ICD-10:
Description
MELAS syndrome, also known as mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, is a rare genetic disorder that affects the nervous system and muscles.
Key Features:
- Mitochondrial dysfunction: MELAS syndrome is caused by mutations in the mitochondria's genetic material (DNA), which leads to impaired energy production in cells.
- Neurological symptoms: The condition primarily affects the brain, causing encephalopathy (brain dysfunction) with seizures and headaches, as well as muscle disease with a lactic acid build-up in the blood.
- Muscle involvement: MELAS syndrome also causes muscle weakness and myopathy (muscle disease).
- Stroke-like episodes: The condition is characterized by recurrent episodes of encephalopathy, which can lead to temporary local paralysis and abnormal thinking (dementia).
Demographics:
- Age of onset: MELAS syndrome typically appears in childhood, with 65-76% of affected individuals presenting at or before age 20 years.
- Gender distribution: The condition affects males and females in equal numbers.
Prevalence: MELAS syndrome is an extremely rare genetic disorder, making it difficult to estimate its exact prevalence. However, it is considered one of the most common types of mitochondrial myopathy caused by mutations in mtDNA.
References:
- [1] MELAS syndrome is a multi-organ disease with broad manifestations including stroke-like episodes, dementia, epilepsy, lactic acidemia, myopathy, recurrent ... (Source: #6)
- [2] Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is an extremely rare genetic condition that begins in childhood. (Source: #4)
- [3] MELAS syndrome is a progressive multisystem disorder that primarily affects the nervous system and the muscles. Although rare, it is one of the most common ... (Source: #9)
- [4] MELAS is a condition that affects many of the body's systems, particularly the brain and nervous system (encephalo-) and muscles (myopathy). In most cases, the signs and symptoms of this disorder appear in childhood following a period of normal development. (Source: #11)
Signs and Symptoms
Common Signs and Symptoms of MELAS Syndrome
MELAS syndrome, a rare genetic disorder, affects multiple systems in the body, particularly the brain and nervous system (encephalo-) and muscles (myopathy). The signs and symptoms of this condition can vary from person to person but often appear in childhood following a period of normal development.
Early Symptoms:
*
Additional Symptoms
- Seizures
- muscle weakness
- nausea
- vomiting
- dizziness
Diagnostic Tests
Treatment
Treatment Options for MELAS Syndrome
MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes) syndrome is a rare mitochondrial disorder that affects the nervous system and muscles. While there is no specific treatment available for MELAS syndrome, various therapies have been explored to manage its symptoms.
- Coenzyme Q10 (CoQ10): Treatment with CoQ10 has been helpful in some patients with MELAS syndrome, as it can help improve energy production in cells [2].
- Anticonvulsant drugs: Anti-convulsant medications are used to prevent and control seizures associated with MELAS syndrome [5]. However, valproic acid should not be used as an anticonvulsant.
- Other treatments: Researchers have also investigated the use of other therapies, such as vitamin supplements (e.g., arginine) and antioxidants, to support energy production in cells and reduce oxidative stress [2].
Current Research and Future Directions
Researchers are actively exploring new treatment options for MELAS syndrome. For example, a study is currently underway to determine the efficacy of a specific drug administered over a one-month period [5]. Additionally, researchers are working on developing treatments that target the underlying mitochondrial dysfunction in MELAS syndrome.
Challenges and Limitations
Despite ongoing research efforts, there are still significant challenges in treating MELAS syndrome. One major hurdle is the heterogeneity of the disorder, which makes it difficult to develop effective treatments [8]. Furthermore, genetic counseling for MELAS syndrome can be challenging due to heteroplasmy, making it essential to identify variations that cause the condition.
References
[2] Treatment with coenzyme CoQ10 has been helpful in some patients with MELAS syndrome. [5] Anti-convulsant medications are used to prevent and control seizures associated with MELAS syndrome. [8] Genetic counseling is challenging due to heteroplasmy.
Recommended Medications
- Antioxidants
- Vitamin supplements (e.g., arginine)
- anticonvulsant
- coenzyme Q10
- ubidecarenone
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Additional Differential Diagnoses
- deafness-dystonia-optic neuronopathy syndrome
- Pearson syndrome
- mitochondrial complex V (ATP synthase) deficiency nuclear type 3
- mitochondrial complex II deficiency
- primary coenzyme Q10 deficiency 1
- primary coenzyme Q10 deficiency 7
- combined oxidative phosphorylation deficiency 52
- combined oxidative phosphorylation deficiency 54
- mitochondrial complex III deficiency nuclear type 1
- congenital myopathy 10B
- CADASIL 2
- combined oxidative phosphorylation deficiency 28
- combined oxidative phosphorylation deficiency 2
- combined oxidative phosphorylation deficiency 24
- X-linked deafness 1
- Leber hereditary optic neuropathy and dystonia
- nuclear type mitochondrial complex I deficiency 5
- nuclear type mitochondrial complex I deficiency 18
- nuclear type mitochondrial complex I deficiency 27
- nuclear type mitochondrial complex I deficiency 12
- combined oxidative phosphorylation deficiency 42
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- rdf-schema#comment
- OMIM mapping confirmed by DO. [SN].
- oboInOwl#id
- DOID:3687
- core#notation
- DOID:3687
- oboInOwl#hasDbXref
- UMLS_CUI:C0162671
- rdf-schema#label
- MELAS syndrome
- oboInOwl#hasExactSynonym
- MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES
- IAO_0000115
- A mitochondrial encephalomyopathy that is characterized by mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes, has_symptom myalgia, motor weakness, headaches, seizures, and stroke-like episodes with acute hemiparesis and severe headaches, and develops_from mutation in mitochondrial genes including MT-TL1, which encodes tRNA proteins.
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- rdf-schema#subClassOf
- t428009
- RO_0002452
- http://purl.obolibrary.org/obo/SYMP_0000504
- relatedICD
- http://example.org/icd10/E88.41
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_10462
- owl#annotatedSource
- t428077
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.